Arxis IPO 2026: $1.13bn raise, Nasdaq debut set

IPO pricing and headline numbers

Arxis said it raised about $1.13 billion in its U.S. initial public offering after pricing shares at $18 each. The Bloomfield, Connecticut-based aerospace parts maker sold 40.5 million shares in an upsized deal. The offer price landed at the top end of the indicated range of $15 to $18 per share cited in the filings and reports around the deal. Shares are expected to begin trading on the Nasdaq Global Select Market on April 16 under the ticker symbol ARXS. The offering is expected to close on April 17, subject to customary closing conditions. The U.S. Securities and Exchange Commission declared the company’s registration statement on Form S-1 effective on April 15.

What changed versus the initial plan

Before pricing, Arxis had disclosed plans to offer 37,735,849 Class A shares within the $15 to $18 range, targeting gross proceeds of up to about $1.06 billion at the top end. The final priced deal was larger, with 40.5 million shares sold at $18, taking gross proceeds to approximately $1.13 billion. Arxis also granted underwriters a 30-day option to purchase up to 6.075 million additional shares at the offering price, less underwriting discounts and commissions. In earlier prospectus materials, a greenshoe of 5,660,377 shares was also referenced in the IPO structure. Taken together, the documents and announcements show an offering that was increased into pricing and supported by broad syndicate participation.

Business profile and end markets

Arxis designs and manufactures electronic and mechanical components used in aerospace and defense, medical technology, and specialized industrial markets. Products cited include seals, gaskets, and metallized fabrics. The defense and space sector is described as its largest end market, representing about 47% of revenue, with commercial aerospace accounting for 23%. The company positions its products as mission-critical components engineered for demanding environments. The listing comes at a time when aerospace suppliers are tapping equity markets to fund expansion and meet rising demand from commercial aviation and defense customers.

Ownership and acquisition-led expansion

Arxis is backed by buyout firm Arcline Investment Management. Under Arcline’s ownership, Arxis has expanded through over 30 acquisitions since 2019, with one set of materials citing 32 acquisitions over that period. A notable transaction highlighted is the $1.8 billion purchase of rival Kaman in 2024. The acquisition track record is central to how Arxis describes its scale-up strategy and platform buildout. This context matters because public-market investors typically scrutinize integration execution and the sustainability of acquisition-driven growth.

Use of proceeds: debt paydown and flexibility

Reports around the IPO said proceeds are primarily designated for debt repayment, aimed at strengthening the balance sheet. Prospectus details included a plan to use approximately $146 million of net proceeds to repay borrowings under its Term Loan Credit Facility. Remaining funds were described as earmarked for working capital and general corporate purposes, including potential acquisitions and investments in complementary businesses. Earlier estimates in the documents put net proceeds at about $130 million at a $16.50 midpoint price, or roughly $1,073 million if the underwriters’ option were exercised in full. The priced deal ultimately came in at $18, but the company’s stated priorities in the materials centered on deleveraging and corporate flexibility.

Financial figures disclosed in materials

The included prospectus-style summary presented 2025 revenue of $1,591.0 million. It also listed net income of $16.0 million for 2025, compared with a net loss of $15.5 million in 2024 and a net loss of $19.9 million in 2023. Adjusted EBITDA was shown at $172.2 million in 2025, $171.3 million in 2024, and $144.0 million in 2023, alongside adjusted EBITDA margins of 35.9%, 32.8%, and 29.5%, respectively. Free cash flow was listed as $108.8 million in 2025, $12.1 million in 2024, and negative $10.4 million in 2023. The same materials referenced pro forma post-IPO debt of $1,915.5 million and pro forma cash of $133.7 million.

Underwriters and syndicate line-up

Goldman Sachs, Morgan Stanley, and Jefferies were named as the lead underwriters and lead joint book-running managers. Citigroup and RBC Capital Markets were listed as joint book-running managers. Baird, Guggenheim Securities, Wells Fargo Securities, William Blair, Rothschild & Co, and Wolfe | Nomura Alliance were listed as book-running managers, with Citizens Capital Markets as co-manager. The breadth of the syndicate reflects a large, widely marketed transaction in the industrial and defense supply chain space.

Key IPO facts at a glance

Market context and why the listing is being watched

The deal was framed as part of a broader push by aerospace suppliers to access equity markets as demand rises from commercial aviation and defense customers. Investor appetite for industrial listings was described as remaining strong in the coverage. Arxis also drew attention earlier for targeting a valuation of up to about $11.2 billion at the top of its proposed range, according to reports tied to its offering terms and filings. Separately, one report noted that cornerstone investors intended to purchase $100 million worth of shares in the offering, representing 40% of the deal as described in that source. These details help explain why the deal was able to price at the top end and be upsized.

Conclusion

Arxis priced its IPO at $18 and increased the share count to raise about $1.13 billion ahead of its Nasdaq debut under ARXS. The company’s filings and reports emphasized debt repayment and balance sheet strengthening, alongside ongoing corporate purposes that can include further acquisitions. With SEC effectiveness confirmed on April 15 and trading expected on April 16, the immediate next milestones are the first day of trading and the anticipated April 17 closing of the offering.